T
Ton Verkerk
Researcher at Erasmus University Rotterdam
Publications - 4
Citations - 611
Ton Verkerk is an academic researcher from Erasmus University Rotterdam. The author has contributed to research in topics: Heterochromatin & Chromatin. The author has an hindex of 4, co-authored 4 publications receiving 577 citations.
Papers
More filters
Journal ArticleDOI
Clasps are CLIP-115 and -170 associating proteins involved in the regional regulation of microtubule dynamics in motile fibroblasts.
Anna Akhmanova,Casper C. Hoogenraad,Ksenija Drabek,Tatiana Stepanova,Bjorn R. Dortland,Ton Verkerk,Wim Vermeulen,Boudewijn M.T. Burgering,Chris I. De Zeeuw,Frank Grosveld,Niels Galjart +10 more
TL;DR: It is proposed that CLASPs are involved in the local regulation of microtubule dynamics in response to positional cues and evidence is provided that this asymmetric CLASP distribution is mediated by PI3-kinase and GSK-3 beta.
Journal ArticleDOI
Characterisation of transcriptionally active and inactive chromatin domains in neurons.
TL;DR: Data indicate that neuronal, perinucleolar heterochromatin consists of several classes of inactive DNA, that are linked to a fraction of the inactive r DNA repeats, which may serve to regulate RNA transcription and processing efficiently and to protect rDNA repeats against unwanted silencing and/or homologous recombination events.
Journal ArticleDOI
The Centromeric/Nucleolar Chromatin Protein ZFP-37 May Function to Specify Neuronal Nuclear Domains
Emmanuel Payen,Ton Verkerk,Dave Michalovich,Sandra D. Dreyer,Andreas Winterpacht,Brendan Lee,Chris I. De Zeeuw,Frank Grosveld,Niels Galjart +8 more
TL;DR: It is suggested that ZFP-37 is a structural protein of the neuronal nucleus which plays a role in the maintenance of specialized chromatin domains in neurons of the adult central nervous system but hardly in testis.
Journal ArticleDOI
Amphotropic retroviruses with a hybrid long terminal repeat as a tool for gene therapy of cystic fibrosis
Martina Wilke,Martina Wilke,Bram Bout,Elly Verbeek,Wendy A. Kappers,Ton Verkerk,Dinko Valerio,Bob J. Scholte +7 more
TL;DR: The data suggest that gene therapy protocols requiring infection in situ, such as in the case of cystic fibrosis, will be hampered by the relatively low local titres that can be achieved at present.